Registry of Lobbyists

Advanced Registry Search Results

Search Criteria

  1. DPOH name: GRIFFITHS, EMILY
Share this search Create an alert

Refine registrations results by

Refine monthly communication reports results by

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Monthly communication reports (4)
Results: 1-4 | Export
  1. Vertex Pharmaceuticals (Canada) Incorporated
    Type: In-house Corporation
    Occurred: 2022-08-17
    Posted: 2022-09-09
    Designated public office holders:
    • Michael Rosu-Miles, Director | Health Canada (HC)
    • Martin Nemec, Senior Biologist/Evaluator | Health Canada (HC)
    • Emily Griffiths, Subject Matter / Technical Specialist | Health Canada (HC)
    • Aswin Hari, Biologist/Evaluator | Health Canada (HC)
    • Denis Arsenault, Manager - Policy Development | Health Canada (HC)
    • Omar Tounekti, Manager, Gene Therapies Division | Health Canada (HC)
    Subject matters:
    • Research and Development
    • Health
    • Science and Technology
  2. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Occurred: 2018-05-22
    Posted: 2018-06-15
    Designated public office holders:
    • Stephanie Hardy, Manager, Policy Unit, Health Products and Therapeutics Branch | Health Canada (HC)
    • Agnes Klein, Senior Medical Advisor, Health Products and Therapeutics Branch | Health Canada (HC)
    • Jemma Fraije, A/ Regulatory Affairs Supervisor, Health Products and Therapeutics Branch | Health Canada (HC)
    • Liz Anne Gillham-Eisen, A Director, Health Products and Therapeutics Branch | Health Canada (HC)
    • Jian Wang, Division Chief, Health Products and Therapeutics Branch | Health Canada (HC)
    • Lindsay Elmgren, Director, Centre for Biologics Evaluation, Health Products and Therapeutics Branch | Health Canada (HC)
    • Emily Griffiths, Subject Matter / Technical Specialist, Health Products and Therapeutics Branch | Health Canada (HC)
    • Cathy Parker, Director General, Health Products and Therapeutics Branch | Health Canada (HC)
    • Evelyn Soo, Associate to the Director General, Health Products and Therapeutics Branch | Health Canada (HC)
    • Georgette Roy, Director, Office of Regulatory Affairs, Health Products and Therapeutics Branch | Health Canada (HC)
    • Michele Chadwick, Manager, Health Products and Therapeutics Branch | Health Canada (HC)
    • Megan Bettle, Director, Health Products and Therapeutics Branch | Health Canada (HC)
    • Karen Reynolds, Executive Director, Strategic Policy Branch | Health Canada (HC)
    • Kelly Robinson, Director, Health Products and Therapeutics Branch | Health Canada (HC)
    • Johanne Veenstra, Senior Regulatory Officer, Health Products and Therapeutics Branch | Health Canada (HC)
    • Anthony Ridgway, Senior Regulatory Scientist, Health Products and Therapeutics Branch | Health Canada (HC)
    Subject matters:
    • Health
  3. The Hospital for Sick Children (SickKids)
    Type: In-house Organization
    Occurred: 2017-11-24
    Posted: 2017-12-15
    Designated public office holders:
    • Daniel Keene, A/Chief, Clinical Trials Division & Head Drug Safety Unit, Health Products and Food Branch | Health Canada (HC)
    • Chad Sheehy, Manager, Clinical Trial and Biological Product Compliance, Regulatory Operations and Regions Branch | Health Canada (HC)
    • Christopher Antonio, Regulatory Affairs Supervisor, Health Products and Food Branch | Health Canada (HC)
    • Emily Griffiths, Policy Analyst, Health Products and Food Branch | Health Canada (HC)
    • Vincent Panetta, Regulatory Affairs Supervisor, Health Products and Food Branch | Health Canada (HC)
    • Agnes Klein, Senior Medical Advisor, DGO, Health Products and Food Branch | Health Canada (HC)
    • Carole Legare, Director, Office of Clinical Trials, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Health
  4. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Occurred: 2017-06-09
    Posted: 2017-08-04
    Designated public office holders:
    • Nick Orphanos, Senior Policy Analyst, Health Products and Food Branch | Health Canada (HC)
    • Stephanie Hardy, Manager, Policy Unit, Health Products and Food Branch | Health Canada (HC)
    • Deryck Trehearne, Director General, Health Products and Food Branch | Health Canada (HC)
    • Wallace Lauzon, Division Chief, Health Products and Food Branch | Health Canada (HC)
    • Agnes Klein, Senior Medical Advisor, Health Products and Food Branch | Health Canada (HC)
    • Cathy Parker, Director General, Health Products and Food Branch | Health Canada (HC)
    • Georgette Roy, Director, Office of Regulatory Affairs, Health Products and Food Branch | Health Canada (HC)
    • Trish Larwill, Senior Policy Advisor, Health Products and Food Branch | Health Canada (HC)
    • Jian Wang, Division Chief, Health Products and Food Branch | Health Canada (HC)
    • Michele Chadwick, Manager, Health Products and Food Branch | Health Canada (HC)
    • Catherine Njue, Biostatistician Advisor - Clinical Trials, Health Products and Food Branch | Health Canada (HC)
    • Liz Anne Gillham-Eisen, A/Director, Health Products and Food Branch | Health Canada (HC)
    • Emily Griffiths, Policy Analyst, Health Products and Food Branch | Health Canada (HC)
    • Anthony Ridgway, Acting Director, Health Products and Food Branch | Health Canada (HC)
    • Ashley Baer, Policy Analyst, Health Products and Food Branch | Health Canada (HC)
    • Jeffrey Skene, Division Chief, Health Products and Food Branch | Health Canada (HC)
    • Sandra Alderdice, Regulatory Affairs Supervisor, Health Products and Food Branch | Health Canada (HC)
    • Laura Johnson, SBD Project Manager, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Health

Date Modified: